Prospect News: News for Rottapharm SpA

E-mail us: service@prospectnews.com Or call: 212 374 2800

Bank Loans - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products

Price: $0.00

Account balance: $0.00

Add to balance / Manage account

User: lxbfYeaa

Log out

Prospect News home > Main news index > All issuers starting with R > Issuers starting with R, HY only > All stories on Rottapharm SpA > Stories on Rottapharm SpA, HY only

Search again

Enter part or all of the issuer name:

Market:

All markets No structured products Bank loans Canadian bonds CLOs Convertibles Distressed debt Emerging markets High yield Investment grade Liability management Municipals PIPEs Preferreds Private placements All leveraged markets Structured products

Market: BK = Bank loans, CV = Convertibles, DD = Distressed Debt, EM = Emerging Markets, HY = High Yield, IG = Investment Grade, LM = Liability Management, MU = Municipals, PP = PIPEs, PF = Preferreds, PV = Private Placements, SP = Structured Products
Recent items, highlighted in orange, are $4.00 each. All others are $1.00 each. Headlines in gray are not currently covered by your subscription.

Rottapharm SpA

3/6/2015	HYLM	Rottapharm to redeem €399.9 million 6 1/8% senior notes due 2019
11/18/2014	HYLM	Rottapharm begins change-of-control offer for €400 million 6 1/8% notes
11/12/2014	HY	S&P: Rottapharm remains on negative watch
8/8/2014	HY	S&P puts Rottapharm on watch
8/5/2014	HY	Moody’s might downgrade Rottapharm
5/21/2014	HY	Moody's might lift Rottapharm
9/10/2013	HY	Moody's: Rottapharm negative
12/21/2012	HY	S&P rates Rottapharm notes BB-
11/8/2012	HY	New Issue: Italy's Rottapharm prices €400 million 6 1/8% seven-year notes at par
11/8/2012	HY	Market Commentary: Sprint sells $2.28 billion; coupon question for Edison; James River off; funds up $82 million
11/7/2012	HY	Rottapharm talks €400 million seven-year notes with 61/4% area yield
11/7/2012	HY	Market Commentary: Vivint leads $2.4 billion day; junk softens post-election; coal drops on vote, James River
11/5/2012	HY	Italy's Rottapharm starts roadshow for €400 million seven-year notes
11/5/2012	HY	S&P rates Rottapharm notes BB-
11/5/2012	HY	Moody's rates Rottapharm notes Ba3
11/5/2012	HY	Market Commentary: New issue calendar ramps up; Clear Channel pushes up; Royal Caribbean deal fades in secondary

©2025 Prospect News. This page is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies, faxing, photocopying or any other form of reproduction.